THU0403 A Randomised, Open-Label Study to Evaluate the Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector
Year: 2015
Type: conference-abstract
Source: Annals of the Rheumatic Diseases
Institutions: IQVIA (United States), GlaxoSmithKline (United Kingdom)
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2380365337
